About
Generic Small Molecules
Areas of Focus
Categories
Generic Drug
Clinical Trials (7)
View allTotal Trials
7
As Lead Sponsor
7
As Collaborator
0
Total Enrollment
769
By Phase
PHASE3: 2PHASE2: 2PHASE1: 3
By Status
COMPLETED: 4RECRUITING: 2ENROLLING_BY_INVITATION: 1
Clinical Trials Pipeline7 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06646354Lead Sponsor
To Evaluate the Efficacy and Safety of Co-administrated HODO-2224-1 and HODO-2224-2 in Patients With Essential Hypertension and Primary Hypercholesterolemia
PHASE3Enrolling by invitation
125 participants
Started: Apr 22, 2025 · Completed: Dec 31, 2028
NCT06647550Lead Sponsor
To Assess the Efficacy and Safety of HD-6277 in Adult Patients With Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
PHASE2Recruiting
160 participants
Started: Dec 12, 2024 · Completed: Dec 31, 2026
NCT06578676Lead Sponsor
To Evaluate the Safety and Pharmacokinetic Interaction Between HODO-22251 and HODO-22252 in Healthy Adults
PHASE1Recruiting
56 participants
Started: Jun 20, 2024 · Completed: Nov 30, 2024
NCT05804279Lead Sponsor
Pharmacokinetics of BPDO-1603 or BPDO-16031 and BPDO-16033 Administration in Healthy Adults
PHASE1Completed
24 participants
Started: Dec 28, 2022 · Completed: Mar 14, 2023
NCT05666128Lead Sponsor
Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet and Exercise
PHASE2Completed
112 participants
Started: Jun 17, 2022 · Completed: Jul 28, 2023
Locations (1)
Headquarters
Gyeonggi, Korea
Map
Loading map...